first_imgMartinez, who had fully dominated Balazs on Friday, was caught in the resumption regardless that he regained the break with which his rival was positioned with a threatening 4-2 on the scoreboard Then he was two factors behind with 5-Four and serve, however in the tenth recreation he misplaced his service once more and the match was equal. In the third spherical, every thing was twisted to the Spaniard, who noticed how the Hungarian endorsed him a devastating 5-0. With all misplaced, Pedro was launched and shortened distances (5-2), however one other break gave Attila the victory, which can play the fourth ATP semifinal of his life. Pedro Martínez stayed one step away from the semifinals of the Open River by falling 2-6, 6-Four and 6-Zero in opposition to the Hungarian Attila Balazs (31 years and 106th) in a recreation that began on Friday and ended this Saturday after being suspended due to the rain with 2-2 in the second set.A pity, as a result of the alzireño, who needed to undergo the earlier one, misplaced a fantastic alternative to battle for the closing of an ATP 500 in the best tournament of his profession in the skilled Tour. It had by no means handed eighths to this point. In truth, he gained his first recreation this yr and did it massive, in the Australian Open in opposition to the German Dominik Koepfer. Having gained in Rio, he would have confronted one other participant of the qualy (like Balazs himself), Gianluca Mager (25 years and 128º), which stunned the first favourite, the Austrian and finalist in Melbourne, Dominic Thiem. In one other recreation suspended on the earlier day, the semi-unknown Mager gained 7-6 (4) and 7-5 and can play the first closing of his profession.last_img read more

first_img1 Jack Grealish Remi Garde has revealed Jack Grealish will return to training with Aston Villa’s first team this week, and the manager will then focus on preparing to face Arsenal, the Frenchman’s former club.The talented Grealish had been forced to train with Villa’s development squad as a punishment for being filmed in a Manchester nightclub hours after the first team’s 4-0 defeat at Everton and amid allegations he also partied at a Birmingham hotel the following day.He again had no involvement in Saturday’s 1-1 Premier League draw at Southampton, but after he has played for the reserves on Monday, Garde – who has overseen two draws and two defeats since his appointment as Villa’s manager – will again consider the 20-year-old for selection.“Jack Grealish will play with the reserve team on Monday and will probably join the group after that,” said Garde, whose previous experience of English football came at Villa’s next visitors, Arsenal, where he was a player in the 1990s.“It’s a very good feeling (to face Arsenal again). But my personal feelings are not very important.“Of course I have very good memories and a strong relationship with this English football club but I know that it is a very good side and they will come to Villa Park to win the game.“For us it will be very tough but I expect my players to be like they were (in the 0-0 draw with Manchester) City.”last_img read more

first_img Source: Reviewed by James Ives, M.Psych. (Editor)Aug 29 2018Philips Healthcare, a global leader in the health technology market, has signed a non-exclusive patent license agreement with the U.S. Air Force Research Laboratory for a mobile software application that provides integrated, real-time patient monitoring.Known as Batdok™, an acronym for Battlefield Assisted Trauma Distributed Observation Kit, the software application was developed by the 711th Human Performance Wing at Wright-Patterson Air Force Base. Designed as a wearable technology, it allows a medic to efficiently monitor multiple casualties in the field using a smartphone or tablet. Adaptation for civilian applications will advance telemedicine capabilities, the company said.Wireless sensors placed on the patient send vitals information to the device, providing medical personnel enhanced decision making when alerted to changes in patient condition. The application also records all vital signs and information logged by the attending staff, with seamless data transfers during patient handoff.Related StoriesSchwann cells capable of generating protective myelin over nerves finds researchAXT enhances cellular research product portfolio with solutions from StemBioSysOlympus Europe and Cytosurge join hands to accelerate drug development, single cell researchThe patent license agreement was completed on July 10. It contains undisclosed financial terms and allows Philips to finalize product development and begin offering solutions to government and civilian customers.”By combining exceptional mobility, user experience, and reliability, Philips will use Batdok™ to improve patient monitoring,” said Kirk Hendler, Philips’ vice-president of business development for government solutions. “This all-in-one mobile solution will enhance care delivery by bringing critical data to decision makers.”Hendler observed the technology in action during military testing last year. After expressing Philips’ interest in the technology, TechLink, the Department of Defense’s national partnership intermediary for technology transfer, assisted Hendler with the preparation of a license application and commercialization plan that included government and civilian applications.”Many of the DoD’s medical inventions have potential dual-use civilian applications,” said Joan Wu-Singel, senior technology manager at TechLink. “In this case, Batdok™ could be used in a hospital setting, ambulances, and we’re even imagining it help address opioid abuse through dosage monitoring.”Dr. Jim Kearns, technology transfer and domestic alliances manager for the 711th Human Performance Wing, said the license proves the value of the Air Force Technology Transfer Program, which ensures unclassified Air Force research is available to industry. The exchange of knowledge, expertise, equipment, and testing facilities allows the U.S. economy to benefit from the public investment in DoD research.”We’re confident Philips will deliver products with multiple levels of benefit,” said Kearns. “The Wing has brilliant people doing cutting-edge research. Collaboration with businesses, case in point, enhances their work and gets it to the warfighter.”last_img read more